April Pettit is an Infectious Disease physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372320011
Telephone
615-322-3000Provider last certified this registry record 30 Mar 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
38.9%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor28.1%Triumeq76%Descovy24%Part D<11 patientsProtease Inhibitor10.9%Atazanavir Sulfate55%Ritonavir45%Part D<11 patientsCardiovascular
31.2%Statin11.6%Atorvastatin Calcium100%Part D<11 patientsACE inhibitor7%Lisinopril100%Part D<11 patients+ 3 more classes in this area
Nervous system
21.4%Gabapentinoids11.2%Gabapentin100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug5.3%Ibuprofen100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Evaluating the Clinical, Economic, and Social Impact of Evolving HIV Prevention and Care Strategies in Tennessee: A Multimethod Approach
Vanderbilt University Medical Center
FY2026$614,700R33MD019323 - Implementation of Rapid HIV Testing and Linkage to HIV Treatment or Prevention Among Vulnerable Populations in Tennessee
Vanderbilt University Medical Center
FY2025$998,423U01PS005240
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”